Induced Pluripotent Stem Cells (iPSCs) Market Report

China Induced Pluripotent Stem Cells (iPSCs) Industry Market Research Report 2023-2029

  • POSTDATE：Oct 05, 2023
  • PAGES：233
  • REPORT CODE：GMM1827870
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Induced Pluripotent Stem Cells (iPSCs) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Astellas Pharma Inc

    • ReproCELL

    • Pluricell Biotech

    • Fate Therapeutics, Inc

    • Fujifilm Holding Corporation (CDI)

    • Ncardia

    • Sumitomo Dainippon Pharma

    By Type:

    • Mouse iPSCs

    • Human iPSCs

    By Application:

    • Toxicity Screening

    • Drug Development and Discovery

    • Academic Research

    • Regenerative Medicine

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Induced Pluripotent Stem Cells (iPSCs) Market Overview 2018-2029

    • 1.1 China Induced Pluripotent Stem Cells (iPSCs) Industry Development Overview

    • 1.2 China Induced Pluripotent Stem Cells (iPSCs) Industry Development History

    • 1.3 China Induced Pluripotent Stem Cells (iPSCs) Industry Market Size (2018-2029)

    • 1.4 China Induced Pluripotent Stem Cells (iPSCs) Market Analysis by Type from Production Side

      • 1.4.1 China Induced Pluripotent Stem Cells (iPSCs) Production Volume, Production Value and Growth Rate of Mouse iPSCs (2018-2029)

      • 1.4.2 China Induced Pluripotent Stem Cells (iPSCs) Production Volume, Production Value and Growth Rate of Human iPSCs (2018-2029)

    • 1.5 China Induced Pluripotent Stem Cells (iPSCs) Market Analysis by Application from Consumption End

      • 1.5.1 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate of Toxicity Screening (2018-2029)

      • 1.5.2 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate of Drug Development and Discovery (2018-2029)

      • 1.5.3 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate of Academic Research (2018-2029)

      • 1.5.4 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate of Regenerative Medicine (2018-2029)

    • 1.6 China Induced Pluripotent Stem Cells (iPSCs) Market Analysis by Region

      • 1.6.1 North China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Induced Pluripotent Stem Cells (iPSCs) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Induced Pluripotent Stem Cells (iPSCs) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Induced Pluripotent Stem Cells (iPSCs) Market Status and Competition Analysis in 2023

      • 2.2.3 China Induced Pluripotent Stem Cells (iPSCs) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Induced Pluripotent Stem Cells (iPSCs) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Induced Pluripotent Stem Cells (iPSCs) Industry Development

    Chapter 3 Induced Pluripotent Stem Cells (iPSCs)Industry Chain Analysis

    • 3.1 Induced Pluripotent Stem Cells (iPSCs) Industry Chain

    • 3.2 Induced Pluripotent Stem Cells (iPSCs) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Induced Pluripotent Stem Cells (iPSCs) Market

    • 3.3 Induced Pluripotent Stem Cells (iPSCs) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Induced Pluripotent Stem Cells (iPSCs) Market

    Chapter 4 China Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 4.1 China Induced Pluripotent Stem Cells (iPSCs) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Induced Pluripotent Stem Cells (iPSCs) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Induced Pluripotent Stem Cells (iPSCs) Production Volume and Growth Rate, by Type

      • 4.5.1 China Induced Pluripotent Stem Cells (iPSCs) Production Volume and Growth Rate of Mouse iPSCs

      • 4.5.2 China Induced Pluripotent Stem Cells (iPSCs) Production Volume and Growth Rate of Human iPSCs

    Chapter 5 China Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Induced Pluripotent Stem Cells (iPSCs) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate, by Application

      • 5.5.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Toxicity Screening

      • 5.5.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Drug Development and Discovery

      • 5.5.3 China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Academic Research

      • 5.5.4 China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Regenerative Medicine

    Chapter 6 China Induced Pluripotent Stem Cells (iPSCs) Market, by Region

    • 6.1 China Induced Pluripotent Stem Cells (iPSCs) Production Volume and Production Value, by Region

    • 6.2 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Sales Value, by Region

    Chapter 7 North China Induced Pluripotent Stem Cells (iPSCs) Market Analysis

    • 7.1 North China Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 7.2 North China Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    Chapter 8 Central China Induced Pluripotent Stem Cells (iPSCs) Market Analysis

    • 8.1 Central China Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 8.2 Central China Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    Chapter 9 South China Induced Pluripotent Stem Cells (iPSCs) Market Analysis

    • 9.1 South China Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 9.2 South China Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    Chapter 10 East China Induced Pluripotent Stem Cells (iPSCs) Market Analysis

    • 10.1 East China Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 10.2 East China Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    Chapter 11 Northeast China Induced Pluripotent Stem Cells (iPSCs) Market Analysis

    • 11.1 Northeast China Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 11.2 Northeast China Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    Chapter 12 Southwest China Induced Pluripotent Stem Cells (iPSCs) Market Analysis

    • 12.1 Southwest China Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 12.2 Southwest China Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    Chapter 13 Northwest China Induced Pluripotent Stem Cells (iPSCs) Market Analysis

    • 13.1 Northwest China Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 13.2 Northwest China Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Astellas Pharma Inc

        • 14.1.1 Astellas Pharma Inc Company Profile

        • 14.1.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 ReproCELL

        • 14.2.1 ReproCELL Company Profile

        • 14.2.2 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pluricell Biotech

        • 14.3.1 Pluricell Biotech Company Profile

        • 14.3.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Fate Therapeutics, Inc

        • 14.4.1 Fate Therapeutics, Inc Company Profile

        • 14.4.2 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Fujifilm Holding Corporation (CDI)

        • 14.5.1 Fujifilm Holding Corporation (CDI) Company Profile

        • 14.5.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Ncardia

        • 14.6.1 Ncardia Company Profile

        • 14.6.2 Ncardia Induced Pluripotent Stem Cells (iPSCs) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Sumitomo Dainippon Pharma

        • 14.7.1 Sumitomo Dainippon Pharma Company Profile

        • 14.7.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Induced Pluripotent Stem Cells (iPSCs) Industry Research Conclusions

    • 15.2 Induced Pluripotent Stem Cells (iPSCs) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Industry Market Size (2018-2029)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Production Volume, Production Value and Growth Rate of Mouse iPSCs (2018-2029)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Production Volume, Production Value and Growth Rate of Human iPSCs (2018-2029)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate of Toxicity Screening (2018-2029)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate of Drug Development and Discovery (2018-2029)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate of Academic Research (2018-2029)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate of Regenerative Medicine (2018-2029)

    • Figure North China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

    • Figure Central China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

    • Figure South China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

    • Figure East China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate from 2018-2029

    • Figure Induced Pluripotent Stem Cells (iPSCs) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Market Share by Type in 2018

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Market Share by Type in 2023

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Production Volume and Growth Rate of Mouse iPSCs (2018-2023)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Production Volume and Growth Rate of Human iPSCs (2018-2023)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Market Share by Application in 2018

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Market Share by Application in 2023

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Total Market Size and Growth Rate from Consumption End

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Toxicity Screening (2018-2023)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Drug Development and Discovery (2018-2023)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Academic Research (2018-2023)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Regenerative Medicine (2018-2023)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Production Volume by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Region (2018-2023)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Production Value by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Production Value Share by Region (2018-2023)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Production Value Share by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Volume by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Region (2018-2023)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Value by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Value Share by Region (2018-2023)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Value Share by Region (2018-2023)

    • Table North China Induced Pluripotent Stem Cells (iPSCs) Production Volume by Type (2018-2023)

    • Table North China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Figure North China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Table North China Induced Pluripotent Stem Cells (iPSCs) Sales Volume by Application (2018-2023)

    • Table North China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Figure North China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Table Central China Induced Pluripotent Stem Cells (iPSCs) Production Volume by Type (2018-2023)

    • Table Central China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Figure Central China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Table Central China Induced Pluripotent Stem Cells (iPSCs) Sales Volume by Application (2018-2023)

    • Table Central China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Figure Central China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Table South China Induced Pluripotent Stem Cells (iPSCs) Production Volume by Type (2018-2023)

    • Table South China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Figure South China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Table South China Induced Pluripotent Stem Cells (iPSCs) Sales Volume by Application (2018-2023)

    • Table South China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Figure South China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Table East China Induced Pluripotent Stem Cells (iPSCs) Production Volume by Type (2018-2023)

    • Table East China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Figure East China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Table East China Induced Pluripotent Stem Cells (iPSCs) Sales Volume by Application (2018-2023)

    • Table East China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Figure East China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Induced Pluripotent Stem Cells (iPSCs) Production Volume by Type (2018-2023)

    • Table Northeast China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Table Northeast China Induced Pluripotent Stem Cells (iPSCs) Sales Volume by Application (2018-2023)

    • Table Northeast China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Induced Pluripotent Stem Cells (iPSCs) Production Volume by Type (2018-2023)

    • Table Southwest China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Table Southwest China Induced Pluripotent Stem Cells (iPSCs) Sales Volume by Application (2018-2023)

    • Table Southwest China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Induced Pluripotent Stem Cells (iPSCs) Production Volume by Type (2018-2023)

    • Table Northwest China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Induced Pluripotent Stem Cells (iPSCs) Production Volume Share by Type (2018-2023)

    • Table Northwest China Induced Pluripotent Stem Cells (iPSCs) Sales Volume by Application (2018-2023)

    • Table Northwest China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share by Application (2018-2023)

    • Table Astellas Pharma Inc Company Profile

    • Table Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Price and Gross (2018-2023)

    • Table ReproCELL Company Profile

    • Table ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Price and Gross (2018-2023)

    • Table Pluricell Biotech Company Profile

    • Table Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Price and Gross (2018-2023)

    • Table Fate Therapeutics, Inc Company Profile

    • Table Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Price and Gross (2018-2023)

    • Table Fujifilm Holding Corporation (CDI) Company Profile

    • Table Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Price and Gross (2018-2023)

    • Table Ncardia Company Profile

    • Table Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Price and Gross (2018-2023)

    • Table Sumitomo Dainippon Pharma Company Profile

    • Table Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US